All In Biotech

Drug Trial Radar · NCT00335101

Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography

Last checked: Nov 20, 2026Latest source record: Apr 29, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Jun 2006

Primary completion

Not stated

Sponsor

Lead sponsor
GE HealthcareIndustry
Sponsor type
Industry
First posted
Jun 8, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is to evaluate and compare the effects on kidney function of three iodinated contrast media (CM) in patients at risk of kidney damage evaluating serum creatinine (Scr) concentrations up to three days after CM administration.

Conditions

  • Coronary Artery Disease (CAD)
  • Renal Impairment
  • Diabetes Mellitus

Interventions

  • Iodixanol, Ioversol, IopromideDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary endpoint:
  2. Maximum peak increase in SCr from baseline up to day 3.
  3. Secondary endpoints:
  4. Change in SCr from baseline to day 2 and to day 3
  5. Number of subjects with contrast-induced nephropathy (CIN)
  6. Quality of diagnostic information

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • GE Healthcare

    Princeton, New Jersey

  • GE Healthcare

    Munich, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.